Hepatocyte mARC1 promotes fatty liver disease
Author:
Publisher
Elsevier BV
Subject
Gastroenterology,Hepatology,Immunology and Allergy,Internal Medicine
Reference34 articles.
1. Epidemiology, pathogenesis, diagnosis and emerging treatment of nonalcoholic fatty liver disease;Makri;Arch Med Res,2021
2. Emerging and future therapies for nonalcoholic steatohepatitis in adults;Mintziori;Expert Opin Pharmacother,2016
3. A missense variant in mitochondrial amidoxime reducing component 1 gene and protection against liver disease;Emdin;PLOS Genet,2020
4. Genome-wide association study for alcohol-related cirrhosis identifies risk loci in MARC1 and HNRNPUL1;Innes;Gastroenterology,2020
5. Association of genetic variation with cirrhosis: a multi-trait genome-wide association and gene–environment interaction study;Emdin;Gastroenterology,2021
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. MiR-337-3p improves metabolic-associated fatty liver disease through regulation of glycolipid metabolism;iScience;2023-11
2. The mitochondrial amidoxime reducing component—from prodrug-activation mechanism to drug-metabolizing enzyme and onward to drug target;Journal of Biological Chemistry;2023-11
3. Therapeutic opportunities for the treatment of NASH with genetically validated targets;Journal of Hepatology;2023-10
4. Unraveling the pathogenesis of non‐alcoholic fatty liver diseases through genome‐wide association studies;Journal of Gastroenterology and Hepatology;2023-08-17
5. Cellular heterogeneity and plasticity during NAFLD progression;Frontiers in Molecular Biosciences;2023-08-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3